Data ArticleNon-isothermal decomposition of 4-((4-fluoro-3-phenoxy- benzylidene) amino) benzenesulfonamide under oxygen atmosphere
-
Add time:09/03/2019 Source:sciencedirect.com
Sulfonamide Schiff's base namely, 4-((4-fluoro-3-phenoxybenzylidene) amino) benzene sulfonamide (4-FBABS) has been synthesized from 4-fluoro-3-phenoxybenzaldehyde, 4-aminobenzenesulfonamide and few drops of glacial acetic acid by condensation method and characterized by microanalysis, Fourier transform Infrared (FT-IR) and NMR (1H and 13C) spectroscopic techniques. The thermal decomposition of 4-FBABS was studied by thermogravimetry/derivative thermogravimetry analysis (TG-DTG) under dynamic oxygen atmosphere at different heating rates of 10, 15 and 20 K min−1. The decomposition process of 4-FBABS is two steps as evidenced from thermogram. The kinetic parameters were estimated using model-free methods (Friedman, Kissinger–Akahira–Sunose (KAS) and Flynn–Wall–Ozawa (FWO)) and model-fitting method (Coats–Redfern (CR)). Invariant kinetic parameters of compound are consistent with the average values obtained by Friedman and KAS isoconversional methods of compound and each step decomposed in different kinetic models. The calculated ∆G≠ values show that the decomposition processes are endothermic and non-spontaneous nature.
We also recommend Trading Suppliers and Manufacturers of 3-(3-FLUORO-PHENOXY)-PROPIONIC ACID (cas 133077-42-6). Pls Click Website Link as below: cas 133077-42-6 suppliers
Prev:Development of gene therapy with a cyclic adenosine monophosphate response element decoy oligodeoxynucleotide to prevent vascular intimal hyperplasia
Next:Short communicationEGFR inhibitors from cancer to inflammation: Discovery of 4-fluoro-N-(4-(3-(trifluoromethyl)phenoxy)pyrimidin-5-yl)benzamide as a novel anti-inflammatory EGFR inhibitor) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- 3D energy framework of a benzophenone acidic dimer09/06/2019
- Synthesis of ethyl 2-[4-(3-fluoro-2-quinoxalinyloxy)phenoxy]propanoate as herbicide09/05/2019
- Short communicationEGFR inhibitors from cancer to inflammation: Discovery of 4-fluoro-N-(4-(3-(trifluoromethyl)phenoxy)pyrimidin-5-yl)benzamide as a novel anti-inflammatory EGFR inhibitor09/04/2019
-
Health and Chemical more >


